Alec Titan
Muscle fasciculation is a common side effect of succinylcholine, a short-acting muscle relaxant used to facilitate endotracheal intubation during surgical procedures. It is characterised by visible motor unit contractions and can be unpleasant for patients, lasting up to 48 hours post-surgery. The exact mechanism behind succinylcholine-induced fasciculation is not fully understood, but it is believed to involve the stimulation of presynaptic acetylcholine receptors and the contraction of intrafusal fibres of muscle spindles. Various pre-treatment modalities, such as non-depolarizing neuromuscular blockers, lidocaine, magnesium, and d-tubocurarine, have been explored to prevent or reduce the incidence and severity of fasciculation and associated myalgia.
| Characteristics | Values |
|---|---|
| Onset of paralysis | Signalled by visible motor contractions called fasciculations |
| Use | Facilitates endotracheal intubation |
| Side effects | Fasciculation, post-operative myalgia, increased serum levels of creatine kinase and potassium, malignant hyperthermia, myoglobinuria, raised intraocular pressure and intracranial pressure |
| Mechanism of fasciculation | Stimulation of presynaptic acetylcholine receptors and contraction of intrafusal fibres of muscle spindles |
| Mechanism of muscle damage | Calcium-induced degradation of phospholipids with the release of damaging products of fatty acid metabolism |
| Prevention | Administration of a small dose of succinylcholine before the subsequent full dose of succinylcholine |
| Prevention | Administration of d-tubocurarine (dTC) or diphenylhydantoin (DPH) as a pretreatment |
| Prevention | Non-depolarizing muscle relaxants, lidocaine, or magnesium |
Explore related products
What You'll Learn
- Succinylcholine is a short-acting muscle relaxant
- It is used to facilitate endotracheal intubation
- It is also used as an adjunct therapy in electroconvulsive shock therapy
- Pretreatment with d-tubocurarine or diphenylhydantoin can prevent succinylcholine-induced fasciculations
- Nondepolarizing muscle relaxants can also prevent fasciculations
Succinylcholine is a short-acting muscle relaxant
The onset of paralysis induced by succinylcholine is typically indicated by visible muscle contractions called fasciculations. Fasciculations are involuntary muscle contractions that can be unpleasant for the patient. The exact mechanism behind fasciculations is not fully understood, but it is believed to involve the stimulation of presynaptic acetylcholine receptors and the contraction of intrafusal fibers of muscle spindles.
To mitigate the occurrence and severity of fasciculations, pretreatment modalities are often employed. For instance, administering a small dose of non-depolarizing neuromuscular blockers (NDMBs) before succinylcholine can reduce the incidence of fasciculations and postoperative myalgia. Rocuronium and vecuronium are also used as pretreatments to prevent or decrease fasciculations and myalgia following succinylcholine administration.
It is important to note that succinylcholine has some side effects, including fasciculations and post-operative myalgias, which can last for up to 48 hours after surgery. The underlying mechanism of muscle damage associated with succinylcholine administration may involve calcium-induced degradation of phospholipids and the release of harmful products of fatty acid metabolism. Therefore, healthcare providers must carefully consider the indications, mechanisms of action, administration methods, adverse effects, and contraindications of succinylcholine to ensure its optimal and safe utilization.
Thigh Muscle Movement: Understanding the Power Source
You may want to see also
Explore related products
It is used to facilitate endotracheal intubation
Succinylcholine is a short-acting depolarizing neuromuscular blockade that is often used to facilitate endotracheal intubation. It is a type of muscle relaxant that blocks the action of acetylcholine, disrupting all cholinergic receptors in the parasympathetic and sympathetic nervous systems. This disruption induces continuous muscle contractions called fasciculations, which are visible motor unit contractions, and subsequent skeletal muscle paralysis.
The use of succinylcholine can be beneficial during certain surgical procedures, especially when abdominal wall muscle disruption is necessary, when mechanical ventilation is difficult, or when a patient's spontaneous respiration may hinder the procedure. It is also used as an adjunct therapy in electroconvulsive shock therapy to control muscle contractions induced by electrical impulses.
Fasciculation and post-operative myalgia are common side effects of succinylcholine administration. The exact mechanism of fasciculation is not fully understood, but it is believed to involve the stimulation of presynaptic acetylcholine receptors and contraction of intrafusal fibers of muscle spindles. To reduce the incidence and severity of these side effects, pretreatment with nondepolarizing neuromuscular blockers (NDMBs), such as a small dose of pancuronium, or drugs like d-tubocurarine (dTC) or diphenylhydantoin (DPH), may be administered before succinylcholine.
Additionally, the administration of a small dose of succinylcholine before the full dose is another strategy to prevent succinylcholine-induced muscle fasciculation. The underlying mechanism of muscle damage associated with succinylcholine may be related to calcium-induced degradation of phospholipids and the release of harmful products of fatty acid metabolism.
Do Dogs' Muscles Vibrate? Understanding Their Pulse
You may want to see also
Explore related products
It is also used as an adjunct therapy in electroconvulsive shock therapy
Succinylcholine is a short-acting depolarizing neuromuscular blocker. It is approved by the FDA as an adjunct to other sedatives or hypnotics. It blocks the action of acetylcholine, disrupting all cholinergic receptors of the parasympathetic and sympathetic nervous systems. Its use can aid in mechanical ventilation by relaxing skeletal muscles.
Succinylcholine is often used as an adjunct therapy in electroconvulsive shock therapy (ECT) to control muscle contractions induced by the electrical impulses delivered during the procedure. ECT is a well-established, safe, and highly effective treatment modality. Anesthesia for ECT requires proper medications and airway management. An induction agent such as methohexital is used for anesthesia, and a neuromuscular blocker such as succinylcholine is used for muscle relaxation. The dose of succinylcholine required for adequate muscle relaxation during ECT is 0.9 mg/kg, although there is variability in patient response.
The onset of paralysis by succinylcholine is signaled by visible muscle contractions called fasciculations. Fasciculations and post-operative myalgias are unpleasant side effects of succinylcholine that can last 24-48 hours after surgery. Pretreatment with nondepolarizing muscle relaxants, lidocaine, or magnesium can prevent fasciculations. Administration of a small dose of succinylcholine before the full dose can also prevent succinylcholine-induced fasciculations.
While succinylcholine is generally safe, it has been associated with hyperkalemia. It is contraindicated in patients with certain conditions, such as mastocytosis, myxedema, and muscular dystrophy, and in those taking aminoglycoside antibiotics or cholinesterase inhibitors. It should also be used with caution in patients at risk for hyperkalemia.
Activating Your Soleus Muscle: Simple and Effective Techniques
You may want to see also
Explore related products
Pretreatment with d-tubocurarine or diphenylhydantoin can prevent succinylcholine-induced fasciculations
Succinylcholine is a short-acting muscle relaxant that facilitates endotracheal intubation. However, its use is associated with certain side effects, the most common of which are muscle fasciculations and post-operative myalgias. These side effects can be unpleasant for patients, lasting up to 24-48 hours after surgery. Fasciculations are visible motor unit contractions that occur during the onset of paralysis induced by succinylcholine. While the exact mechanism behind these fasciculations is not fully understood, it is believed to involve the stimulation of presynaptic acetylcholine receptors and the contraction of intrafusal fibers of muscle spindles.
To mitigate these unwanted side effects, various pre-treatment modalities have been explored, including the use of d-tubocurarine (dTC) or diphenylhydantoin (DPH) as a pretreatment option. Experiments have been conducted to understand the nature of drug-drug interactions, the sites of interaction, and the specific location of fasciculation suppression. D-tubocurarine pretreatment has been specifically studied for its impact on succinylcholine twitch augmentation and neuromuscular blockade. Additionally, the optimal interval between the pretreatment dose of d-tubocurarine and the administration of succinylcholine has been investigated.
Diphenylhydantoin (DPH) has also been evaluated as a pretreatment option to prevent succinylcholine-induced fasciculations. The effectiveness of DPH in suppressing fasciculations is believed to be related to its ability to interact with succinylcholine and modify its effects. By administering DPH before succinylcholine, the incidence and severity of fasciculations can be reduced, providing a more comfortable experience for patients during and after surgery.
Furthermore, non-depolarizing neuromuscular blockers (NDMBs) have been used to prevent fasciculations and decrease postoperative myalgia. These blockers are thought to work by inhibiting pre-junctional nicotinic receptors. Additionally, administering a small dose of succinylcholine before the full dose, a technique known as "de-fasciculation," can also help prevent succinylcholine-induced fasciculations. This approach has been compared with the use of pancuronium, a de-fasciculating agent, to reduce the side effects of succinylcholine.
In summary, the prevention of succinylcholine-induced fasciculations and myalgias is an important area of research to enhance patient comfort during surgical procedures. The use of pretreatment drugs like d-tubocurarine and diphenylhydantoin, along with other modalities, offers promising strategies to mitigate these unwanted side effects. Further studies and clinical trials are conducted to optimize the dosage and timing of these pretreatments to ensure maximum effectiveness in preventing succinylcholine-induced fasciculations.
Unlocking Psoas Muscle Flexibility: Simple Stretching Techniques
You may want to see also
Nondepolarizing muscle relaxants can also prevent fasciculations
Succinylcholine is a depolarizing NMJ-blocking drug that binds to ACh receptors and causes a prolonged depolarization of the motor end plate, resulting in flaccid paralysis. This paralysis is usually signalled by visible motor unit contractions called fasciculations. Fasciculations are muscular twitches that occur during the depolarization of muscle fibres. The exact mechanism of fasciculation is not known, but stimulation of presynaptic acetylcholine receptors and contraction of intrafusal fibres of muscle spindles are believed to contribute.
Other nondepolarizing muscle relaxants that can prevent fasciculations include lidocaine and magnesium. Pretreatment with a small dose of non-depolarizing neuromuscular blocker before succinylcholine is commonly practised to lessen the incidence and severity of postoperative myalgia. Rocuronium and vecuronium pretreatment can also be used to prevent fasciculations, myalgia, and biochemical changes following succinylcholine administration.
Tongue Twisters: Muscles Behind Rolling Your Rs
You may want to see also
Frequently asked questions
Muscle fasciculation is the visible contraction of motor units.
Muscle fasciculation can be caused by the administration of succinylcholine, a short-acting muscle relaxant used to facilitate endotracheal intubation.
The most common side effects of succinylcholine are muscle fasciculation and post-operative myalgias, which can last up to 48 hours after surgery. Other side effects include increased serum levels of creatine kinase and potassium, malignant hyperthermia, myoglobinuria, and raised intraocular and intracranial pressure.
Succinylcholine-induced muscle fasciculation can be prevented by administering a small dose of succinylcholine before the full dose or by using non-depolarizing neuromuscular blockers such as pancuronium, lidocaine, magnesium, d-tubocurarine, or diphenylhydantoin.
The exact mechanism of succinylcholine-induced muscle fasciculation is not known, but it is believed to involve stimulation of presynaptic acetylcholine receptors and contraction of intrafusal fibers of muscle spindles.
